Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension

Yinan Shi(Indiana University – Purdue University Indianapolis), Haiyang Tang(University of Arizona)
Frontiers in Pharmacology
November 11, 2021
Cited by 17


Related Papers

Endothelial HIF-2α Contributes to Severe Pulmonary Hypertension by Inducing Endothelial-to-Mesenchymal Transition
|American Journal of Physiology-Lung Cellular and Molecular Physiology|2017|180